| • | | an indemnification agreement, dated as of February 4, 2021, by and between the Company and Richard M. Jelinek, a copy of which is attached as Exhibit 10.10 hereto and incorporated herein by reference; |
| • | | an indemnification agreement, dated as of February 4, 2021, by and between the Company and Roma Khanna, a copy of which is attached as Exhibit 10.11 hereto and incorporated herein by reference; |
| • | | an indemnification agreement, dated as of February 4, 2021, by and between the Company and Michael Rubenstein, a copy of which is attached as Exhibit 10.12 hereto and incorporated herein by reference; |
| • | | an indemnification agreement, dated as of February 4, 2021, by and between the Company and Vijay K. Sondhi, a copy of which is attached as Exhibit 10.13 hereto and incorporated herein by reference; and |
| • | | an indemnification agreement, dated as of February 4, 2021, by and between the Company and Michael Vorhaus, a copy of which is attached as Exhibit 10.14 hereto and incorporated herein by reference. |
Item 3.02 Unregistered Sales of Equity Securities.
Simultaneously with the closing of the IPO, the Company completed the private sale of an aggregate of 9,900,000 warrants (the “Private Placement Warrants”) to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $9,900,000. The Private Placement Warrants are identical to the warrants sold as part of the Units in the IPO, except that the Sponsor has agreed not to transfer, assign or sell any of the Private Placement Warrants (except to certain permitted transferees) until thirty (30) days after the completion of the Company’s initial business combination. The Private Placement Warrants are also not redeemable by the Company so long as they are held by the Sponsor or its permitted transferees. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 4, 2021, in connection with the IPO, Mr. Beebe, Mr. Brown, Mr. Jelinek, Ms. Khanna, Mr. Rubenstein, Mr. Sondhi and Mr. Vorhaus were appointed to the board of directors of the Company (the “Board”). Each of Mr. Beebe, Mr. Brown, Mr. Jelinek, Ms. Khanna, Mr. Rubenstein, Mr. Sondhi and Mr. Vorhaus is an independent director. Effective February 4, 2021, Mr. Jelinek, Mr. Rubenstein and Mr. Vorhaus were appointed to the Audit Committee of the Board, with Mr. Jelinek serving as the chair of the Audit Committee. Effective February 4, 2021, Mr. Brown, Mr. Jelinek and Mr. Sondhi were appointed to the Compensation Committee of the Board, with Mr. Brown serving as the chair of the Compensation Committee. Effective February 4, 2021, Mr. Brown, Ms. Khanna and Mr. Rubenstein were appointed to the Nominating Committee of the Board, with Mr. Brown serving as the chair of the Nominating Committee
Following the appointment of Mr. Beebe, Mr. Brown, Mr. Jelinek, Ms. Khanna, Mr. Rubenstein, Mr. Sondhi and Mr. Vorhaus, the Board is comprised of the following three classes: (i) the term of office of the first class of directors, consisting of Mr. Beebe, Mr. Brown and Mr. Jelinek, will expire at the Company’s first annual meeting of shareholders; (ii) the term of office of the second class of directors, consisting of Ms. Khanna and Mr. Rubenstein, will expire at the Company’s second annual meeting of shareholders; and (iii) the term of office of the third class of directors, consisting of Mr. Sondhi, Mr. Vorhaus and Mr. Wasserman, will expire at the Company’s third annual meeting of shareholders.
On February 4, 2021, in connection with their appointments to the Board, each of Mr. Beebe, Mr. Brown, Mr. Jelinek, Ms. Khanna, Mr. Rubenstein, Mr. Sondhi and Mr. Vorhaus entered into the Letter Agreement as well as an indemnity agreement with the Company. In addition, on January 28, 2021, the Sponsor transferred 25,000 Class B ordinary shares, par value $0.0001, of the Company to each of Mr. Beebe, Mr. Brown, Mr. Jelinek, Ms. Khanna, Mr. Rubenstein, Mr. Sondhi and Mr. Vorhaus.
3